No categories for this tab

HP

Hiray Pharma Solutions Ltd.

Service Provider · Contract & Outsourcing ServicesChina

589

42

7

4.7(68)

About Company

Legal Name: Hiray Pharma Solutions Ltd.
International Name: Hiray Pharma Solutions Ltd., China
Brand / Trade Name: Hiray Pharma Solutions
Registered country: China
Address: HubeiJingmenNo. 1, Xinghua 3rd Road, Daodao District, Jingmen City, Hubei Province • Hubei

Description:

Hiray Pharma Solutions (Hanrui Pharmaceutical, Jingmen), established January 2019 as a wholly-owned subsidiary of Wuhan Haite Biopharmaceutical, operates from a 90,500-square-meter industrial recycling park site in Jingmen City, Hubei, built around seven planned workshops and an API production line with reactors ranging from 30L to 10,000L across 105 units. The company has obtained manufacturing qualifications for APIs including Urapidil Hydrochloride and peramivir, and has established business relationships with five of the world's top ten innovative pharmaceutical companies, working toward its stated vision of becoming a world-class API CDMO enterprise with quality systems aligned to FDA, EMA, and NMPA requirements. It offers CRO and CMO services, custom formulation, and consultation, manufacturing under OEM, ODM, and its own brand, and ships to North America, Asia, Western and Eastern Europe, and Central/South America.

Business Activities

Contract & Outsourcing Services

Service ProviderCDMO / CMO

Laboratory Chemicals, Solvents & Reference Standards

ManufacturerRetailerService Provider

Pharma Chemicals

ManufacturerService ProviderRetailer

Our Products & Services

Sell · Pharma Chemicals

Hiray Pharma Solutions Ltd.

About Company

Business Activities

Contract & Outsourcing Services

Laboratory Chemicals, Solvents & Reference Standards

Pharma Chemicals

Our Products & Services

1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-teChemicalbooktrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahyd

(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride 2212022-57-4

Certifications

GMP multifunctional and 4 GMP commercial workshops for APIs

GMP workshops for intermediates

GMP multifunctional workshops

GMP commercial workshops and 6 Non-GMP workshops

Ratings

Leave your rating & comment

Comments

(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one 2212022-56-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- 2212022-55-2

1-(4-Methoxyphenyl)-2-benzylaminopropane

1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dime

1H-Indole-2-carboxamide, 1-[(1S,2S)-1-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- 2212021-82-2

[(1s,2s,4s)-4-amino-3-Hydroxy-5-phenyl-1-phenylmethyl]pentyl-1,1-dimethylethyl ester)

2-Bromo-4'-Benzyloxy-3'-nitroacetophenone

2-CHLOROETHYL METHYL SULFIDE

decahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan-2(1H)-one

(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate 2212021-56-0

4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride 2212021-40-2

5-bromo -4-fluoro -1-methyl -1H-indazole/5-Bromo-4-fluoro-1-methyl-1H-indazole

5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid 2212021-83-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- 2212021-59-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl e 2212021-61-7

Compound T11408/2212020-52-3

ORFORGLIP1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-RON intermediate/ 2212021-81-1

ORFORGLIPRON N-7 3047293-01-3

ORFORGLIPRON N-8 3047292-99-6

(S)-3-Aminobutanenitrile hydrochloride 1073666-54-2

(S)-3-Aminobutanenitrile hydrochloride

(S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide 2212021-79-7

Santillactone (racemate)/decahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan-2(1H)-one 1216-84-8

Urolith A 1143-70-0

Active Pharmaceutical Ingredients (APIs)

Manufacturing Equipment & Utilities